Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact of Preceding Therapy of CART Cells in B-ALL and impact of consolidative HCT following complete remission post CART

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

GoCART Coalition

Type de traitement

Investigateur principal

Valentín ORTIZ-MALDONADO

Practice patterns of holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Gloria Iacoboni, MD, PhD, Pere Barba, MD, PhD

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Friedrich Stoelzel

Thrombotic microangiopathy (TMA) after CAR-T cell therapy

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Guillaume Dachy

CAR-T cell outcomes in patients with comorbidities

Études rétrospectives

Toutes les maladies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Practices and management of post-transplant haemorrhagic cystitis in patients who undergo allogeneic haematopoietic stem cell transplantation

Toutes les maladies

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

Fusarium infections in allogeneic hematopoietic cell transplant recipients

Études rétrospectives

Complications : infectieuses

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

Mixed chimerism after related CB HSCT with hemoglobinopathies

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Vanderson Rocha (Brazil)

Comparison of late complications after HCT using Treosulfan based and Busulfan based conditioning regimen for Hemoglobinopathy

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Maura Faraci (Genova)

National Access and need for CAR-T CD19 therapy in Euro region

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Aleksandra Oszer(Lodz)

Accès national et besoins en thérapie CAR-T CD19 dans la région Euro

Études rétrospectives

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Aleksandra Oszer(Lodz)

Post-transplant immune intervention in paediatric AML.

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal